Providence details improvements for prevention of sepsis in newborns

Group B streptococcus is notorious for leading to sepsis in newborns. While there are guidelines for treating the condition, adhering to them is not always followed. 

Advertisement

Renton, Wash.-based Providence, in collaboration with the CDC and the Oregon Health Authority and the CDC, worked to develop a new dynamic admission labor/induction order within the patient’s electronic medical record. The practice is modeled after the CDC “Prevent GBS” mobile app, according to a Feb. 13 news release shared with Becker’s. 

The shift in best practices related to this type of neonatal care led to an increase in the appropriate treatment of preterm patients, according to the research, which was published in November 2023 in the American Journal of Perinatology. 

“The findings show that even simple clinical innovations can significantly elevate our ability to improve neonatal health outcomes,” Maulin Shah, MD, chief medical information officer at Providence, adding  that “GBS can result in infections in the blood and brain for newborns.”

Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit

Advertisement

Next Up in Infection Control

Advertisement

Comments are closed.